other material
confidence high
sentiment neutral
materiality 0.75
4D Molecular Therapeutics raises ~$281.4M in public offering of common stock and pre-funded warrants
4D Molecular Therapeutics, Inc.
- Sold 6,586,015 shares at $29.50/share and pre-funded warrants for 3,583,476 shares at $29.4999 each.
- Underwriters granted 30-day option to purchase up to 1,525,423 additional shares.
- Net proceeds ~$281.4M after underwriting discounts and expenses; offering closed Feb 9, 2024.
- Directors and officers subject to lock-up until April 6, 2024 without underwriter consent.